NCT06033378 Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.
| NCT ID | NCT06033378 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-09-01 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An MRI study to examine the relationship between blood pressure and cerebral blood flow in patients with subarachnoidal hemorrhage and suspect or verified vasospasm.
Eligibility Criteria
Inclusion Criteria: * Coiled or clipped aneurysm * Suspected or confirmed vasospasm Exclusion Criteria: * BMI \>30 * Pregnancy * Pacemaker or other MRI contraindications * Severe congestive heart failure (NYHA III-IV) or cardiac arrhythmia. * Severe respiratory failure or FiO2 \>0.6 * Severe kidney failure
Contact & Investigator
Laleh Zarrinkoob
PRINCIPAL INVESTIGATOR
Region Västerbotten
Frequently Asked Questions
Who can join the NCT06033378 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06033378 currently recruiting?
Yes, NCT06033378 is actively recruiting participants. Contact the research team at laleh.zarrinkoob@umu.se for enrollment information.
Where is the NCT06033378 trial being conducted?
This trial is being conducted at Umeå, Sweden.
Who is sponsoring the NCT06033378 clinical trial?
NCT06033378 is sponsored by Umeå University. The principal investigator is Laleh Zarrinkoob at Region Västerbotten. The trial plans to enroll 30 participants.